Evon Medics, LLC is focused on developing and delivering breakthrough therapeutics and devices to address brain-related conditions and functions including: improvement of cognitive function in pre-Alzheimer’s conditions such as mild cognitive impairment (MCI), prevention of progressive neurodegeneration in early Alzheimer’s disease, and regulation of emotional instability in neurodegenerative diseases. Our research development efforts also focus on innovative methodologies and applications for restoration of brain function following traumatic head injuries, prevention of relapse during recovery from opioid addiction, treatment of chronic pain, and rapid enhancement of mood in treatment-refractory depression.